Genmab — Marts 2020
-
Daratumumab in Transfusion-Dependent Participants - turned into a Dara-only trial, some results, extended for a year https://clinicaltrials.gov/ct2/history/NCT03011034?A=24&B=25&C=merged#StudyPageTop
-
Scientists from Rotterdam&Utrecht clam to have discovered a human monoclonal antibody that is able to block an infection of COVID-19 https://www.erasmusmagazine.nl/en/2020/03/14/unique-discovery-in-erasmus-mc-antibody-against-corona/?noredirect=en_US
-
God morgen.
-
Aktieposten i curevac kan blive værdifuld https://e24.no/internasjonal-oekonomi/i/zG1wy4/usa-og-tyskland-i-vaksinedragkamp
-
Hej folkens. Jeg er ved at skrive en stor skriftlig opgave på HHX omkring investering i Genmab, så jeg sidder lige og forsøger at sætte mig ind i deres forretning. Som jeg har forstået så forsker Genmab i antibody teknologi og dens effekt på forskellige typer kræft. Produktionen af præperater, foregår vel hos partnerne? Darzalex ved J&J og Arzerra ved Novartis ikke? Og af de salg de så laver, får Genmab deres royalties fra. Som deres omsætning så består af. Tak på forhånd

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind